Sepsis Diagnostic Excellence and its Association with Mortality in Adults with Potential Infection

BACKGROUND: Diagnostic uncertainty in sepsis contributes to both undertreatment (delayed antibiotics) and overtreatment (unnecessary early antibiotics in non-sepsis patients). We hypothesized hospitals with high relative performance on sepsis undertreatment and overtreatment measures have improved patient outcomes. METHODS: We conducted a retrospective cohort study of hospitalized adults at 20 hospitals (Advocate Health, Michigan Medicine) between 2022-2024. Patients met ≥2 systemic inflammatory response syndrome criteria within 6 hours of presentation. Hospital-level diagnostic performance was characterized using risk-standardized rates (RSR) for undertreatment and overtreatment. "Diagnostic Excellence" (DxEx) was prespecified as top-tertile performance in one measure without bottom-tertile performance in the other. The primary outcome was hospital mortality or hospice discharge. Secondary outcomes were hospital-free days alive at 28 days (HFD), length of stay (LOS), and total antibiotic days. RESULTS: Among 152,779 patients, 49,109 (32.1%) received antibiotics within 3 hours and 16,361 (10.7%) ultimately met sepsis criteria. Undertreatment RSRs ranged 29.3%-46.8%. Overtreatment RSRs ranged 21.5%-37.2%. There was negative correlation between performance ranks (τ=-0.51, p=0.01). Four hospitals met DxEx criteria. Receiving treatment at DxEx hospitals was associated with lower odds of hospital mortality or hospice discharge (adjusted OR=0.61, 95% Confidence Interval [95%CI]=0.41-0.90; p=0.01), greater HFD (adjusted difference=0.59, 95%CI=0.04-1.14; p=0.04), reduced LOS (adjusted difference=-1.20, 95%CI=-2.23- -0.17; p=0.02), and fewer antibiotic days (adjusted difference=-0.62, 95%CI=-1.28-0.05; p=0.07), versus non-DxEx hospitals. CONCLUSIONS: Hospital performance that jointly minimizes sepsis undertreatment and overtreatment was associated with improved patient outcomes, after adjustment for patient and hospital factors. These findings highlight the importance of reducing diagnostic error in efforts to improve sepsis outcomes.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2026-06-30
DOI
https://doi.org/10.1093/cid/ciag382
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sepsis Diagnostic Excellence and its Association with Mortality in Adults with Potential Infection

Chadwick D. Miller, Shuo Tian, Sachita Shrestha, MARC KOWALKOWSKI et al.
Clinical Infectious Diseases
Sepsis Diagnosis and Treatment
article

Sepsis Diagnostic Excellence and its Association with Mortality in Adults with Potential Infection

Chadwick D. Miller, Shuo Tian, Sachita Shrestha, MARC KOWALKOWSKI, Stephanie Taylor, Jessie King, Sarah Birken, B Rowland, J A Palakshappa, Laura Clark, Corey Obermiller, Timothy Rogers
article en

Abstract

BACKGROUND: Diagnostic uncertainty in sepsis contributes to both undertreatment (delayed antibiotics) and overtreatment (unnecessary early antibiotics in non-sepsis patients). We hypothesized hospitals with high relative performance on sepsis undertreatment and overtreatment measures have improved patient outcomes. METHODS: We conducted a retrospective cohort study of hospitalized adults at 20 hospitals (Advocate Health, Michigan Medicine) between 2022-2024. Patients met ≥2 systemic inflammatory response syndrome criteria within 6 hours of presentation. Hospital-level diagnostic performance was characterized using risk-standardized rates (RSR) for undertreatment and overtreatment. "Diagnostic Excellence" (DxEx) was prespecified as top-tertile performance in one measure without bottom-tertile performance in the other. The primary outcome was hospital mortality or hospice discharge. Secondary outcomes were hospital-free days alive at 28 days (HFD), length of stay (LOS), and total antibiotic days. RESULTS: Among 152,779 patients, 49,109 (32.1%) received antibiotics within 3 hours and 16,361 (10.7%) ultimately met sepsis criteria. Undertreatment RSRs ranged 29.3%-46.8%. Overtreatment RSRs ranged 21.5%-37.2%. There was negative correlation between performance ranks (τ=-0.51, p=0.01). Four hospitals met DxEx criteria. Receiving treatment at DxEx hospitals was associated with lower odds of hospital mortality or hospice discharge (adjusted OR=0.61, 95% Confidence Interval [95%CI]=0.41-0.90; p=0.01), greater HFD (adjusted difference=0.59, 95%CI=0.04-1.14; p=0.04), reduced LOS (adjusted difference=-1.20, 95%CI=-2.23- -0.17; p=0.02), and fewer antibiotic days (adjusted difference=-0.62, 95%CI=-1.28-0.05; p=0.07), versus non-DxEx hospitals. CONCLUSIONS: Hospital performance that jointly minimizes sepsis undertreatment and overtreatment was associated with improved patient outcomes, after adjustment for patient and hospital factors. These findings highlight the importance of reducing diagnostic error in efforts to improve sepsis outcomes.

Clinical Infectious Diseases
Advocate Health Care (US), Michigan Medicine (US), Wake Forest University (US)
Good health and well-being
Openalex Percentile: Top 8%
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.